Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Structure Therapeutics Inc. Sponsored ADR (GPCR) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-122.53M |
|
-- |
|
-- |
|
$158.23M |
|
$-158.23M |
|
$36.01M |
|
$-122.22M |
|
$-122.22M |
|
$-122.53M |
|
$-122.53M |
|
$-122.53M |
|
$-122.53M |
|
$-158.23M |
|
$-175.70M |
|
52.64M |
|
52.64M |
|
$-2.33 |
|
$-2.33 |
|
| Balance Sheet Financials | |
$891.21M |
|
$3.48M |
|
$12.12M |
|
$903.33M |
|
$36.02M |
|
-- |
|
$2.47M |
|
$38.49M |
|
$864.84M |
|
$864.84M |
|
$864.84M |
|
57.29M |
|
| Cash Flow Statement Financials | |
$-116.64M |
|
$-358.91M |
|
$515.26M |
|
$129.79M |
|
$169.51M |
|
$39.72M |
|
$18.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.74 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-117.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.17% |
|
-14.17% |
|
-13.56% |
|
-14.17% |
|
$15.10 |
|
$-2.24 |
|
$-2.22 |
|